安藤　亮　業績集

英文業績（２００１年から現在まで）

IF (impact factor)：　2023年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

6

19.0

3.2

Corresponding author

1

0.9

0.9

Second author

1

2.3

2.3

その他

25

69.8

2.8

英文全業績

33

91.1

2.8

 

 

  1. Mitamura M, Saito M, Hirooka K, Dong Z, Ando R, Kase S, Ishida S. AI-based analysis of surgical outcomes in vitrectomy with and without cystotomy for refractory cystoid diabetic macular edema. Sci Rep. in press
  2. Saito M, Mitamura M, Yokoi K, Hirooka K, Dong Z, Ando R, Kase S, Ishida S. Choroidal blood flow velocity and resistance in inferior posterior staphyloma using a novel superpixel technique in laser speckle flowgraphy. Sci Rep. in press
  3. Mitamura M, Saito M, Fukutsu K, Dong Z, Ando R, Kase S, Noda K, Shiba R, Isogai N, Dohke M, Kase M, Ishida S. Sex differences in age-related changes in retinal arteriovenous area based on deep learning segmentation model. Ophthalmol Sci. in press
  4. Mitamura M, Saito M, Hirooka K, Dong Z, Ando R, Kase S, Ishida S. Differences in artificial intelligence-based macular fluid parameters between clinical stages of diabetic macular edema and their relationship with visual acuity. J Clin Med. 2025; 14: 1007
  5. Saito M, Mitamura M, Fukutsu K, Dong Z, Ando R, Kase S, Katsuta S, Ishida S. Retinal Arteriovenous Information Improves the Prediction Accuracy of Deep Learning-Based baPWV Index From Color Fundus Photographs. Invest Ophthalmol Vis Sci. 2025; 66: 63
  6. Ota J, Ando R, Motegi H, Sugino H, Mitsuhashi T, Ishida S. Acute acquired comitant esotropia associated with Lhermitte-Duclos disease: a case report. J Med Case Rep. 2024; 18: 365
  7. Ando R, Hirooka K, Saito M, Kase S, Noda K, Ishida S. Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Jpn J Ophthalmol. 2023; 67: 50-58
  8. Iwasaki M, Ando R, Aoki S, Miyamoto H. Restoration process of the outer retinal layers after surgical macular hole closure. Retina. 2022; 42: 313-320
  9. Murata M, Noda K, Kase S, Hase K, Wu D, Ando R, Ishida S. Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity. J Biol Chem. 2022; 298: 102378
  10. Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, Ishida S. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022; 28: 101732
  11. Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K,Ishida S. Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: Novel subtype of multiple drusen. Am J Ophthalmol. 2018; 196: 181-196
  12. Ishikawa Y, Hashimoto Y, Saito W, Ando R, Ishida S. Blood flow velocity and thickness of the choroid in a patient with chorioretinopathy associated with ocular blunt trauma. BMC Ophthalmol. 2017; 17: 86
  13. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
  14. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon.2016; 2: e00191
  15. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol. 2016; 9: 1100-1105
  16. Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Noda K, Ishida S. Clinical and histological evaluation of large macular hole surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2016; 11: 9-14
  17. Ando R, Noda K, Namba S, Saito W, Kanda A, Ishida S. Aqueous humor levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol. 2014; 92: 245-246
  18. Ando R, Noda K, Tomaru U, Kamoshita M, Ozawa Y, Notomi S, Hisatomi T, Noda M, Kanda A, Ishibashi T, Kasahara M, Ishida S. Decreased Proteasomal Activity Causes Photoreceptor Degeneration in Mice. Invest Ophthalmol Vis Sci. 2014; 55: 4682-4690
  19. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  20. Kinoshita S, Noda K, Tagawa Y, Inafuku S, Dong Y, Fukuhara J, Dong Z, Ando R, Kanda A, Ishida S. Genistein Attenuates Choroidal Neovascularization. J Nutr Biochem. 2014; 25: 1177-1182
  21. Kinoshita S, Kase S, Ando R, Dong Z, Fukuhara J, Dong Y, Takashina S, Noda K, Noda M, Kanda A, Ishida S. Expression of vascular endothelial growth factor in human ocular adnexal lymphoma. Invest Ophthalmol Vis Sci. 2014; 55: 3461-3467
  22. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis. 2014; 7;20:171-177
  23. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3751
  24. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19: 536-543
  25. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  26. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389（査読有）
  27. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. AlphaB-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina. 2012; 32: 1190-1196
  28. Fukuhara J, Kase S, Noda K, Kanda A, Murata M, Noda M, Ando R, Dong Z, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res. 2012; 48: 33-37
  29. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, Ohguchi T, Kawakita T, Ohno S, Ishida S. Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis. 2012; 18: 455-464
  30. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  31. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17:63-69
  32. Hashimoto A, Hashimoto S, Ando R, Noda K, Ogawa E, Kotani H, Hirose M, Menju T, Morishige M, Manabe T, Toda Y, Ishida S, Sabe H. GEP100-Arf6-AMAP1-Cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS ONE. 2011; 6:e23359
  33. Ando R, Shinmei Y, Nitta T, Yoshida K, Chin S, Kase M, Ohno S. Central serous retinal detachment detected by optical coherence tomography in Leber's idiopathic stellate neuroretinitis. Jpn J Ophthalmol. 2005; 49: 547-548